Skip to content

Efficacy and Safety in Self-Prepared Nasal Saline Irrigation and Clinical Outcome in Patient with Allergic Rhinitis

Efficacy and Safety in Self-Prepared Nasal Saline Irrigation and Clinical Outcome in Patient with Allergic Rhinitis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160120001
Enrollment
264
Registered
2016-01-20
Start date
2016-01-20
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1.Allergic rhinitis 1.Allergic rhinitis 2.Self prepared 3.Saline irrigation 4.Hypertonic saline 5.Isotonic saline

Interventions

Adjuvant therapy 0.9% NaCl irrigate 2 time per day&#44
80 ml per nostril ,Adjuvant therapy 1.8% NaCl irrigate 2 time per day&#44
80 ml per nostril ,Adjuvant therapy 0.9% NaCl irrigate 2 time per day&#44
80 ml per nostril
normal saline ,Hypertonic saline ,Normal saline (klean & kare)

Sponsors

Faculty of pharmacy , Mahasarakham university
Lead Sponsor
Faculty of pharmacy &#44
Collaborator
Mahasarakham university
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-65 years,all gender. 2.Underlying disease is Allergic disease. 3.Have a running nose with these symtoms at least 1 symptom 3.1 sneezing 3.2 congestion 3.3 itching 3.4 conjunctivitis

Exclusion criteria

Exclusion criteria: 1.Seafood allergy. 2.Have an abnormal in internal nostril. 3.Have a sign of infection (fever,body temperature>38 celcius or purulent in nostril or pain in nostril or get an antibiotic) 4.Tumor in nostril. 5.Abnormal structure of septum nose. 6.Abnormal mucocialiary

Design outcomes

Primary

MeasureTime frame
Quality of life At 1 months after end of intervention Rcq-36

Secondary

MeasureTime frame
Total nasal symptom score At 1 months after end of intervention TNSS

Countries

Thailand

Contacts

Public ContactKrongkwan Duangpawang

Faculty of pharmacy

Krongkwan.d@msu.ac.th+66 43-754-360

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026